Cargando…
Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
The immunogenic clonal-fraction threshold in heterogeneous solid-tumor required to induce effective bystander-killing of non-immunogenic subclones is unknown. Pancreatic cancer poses crucial challenges for immune therapeutic interventions due to low mutational-burden and consequent lack of neoantige...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475277/ https://www.ncbi.nlm.nih.gov/pubmed/32862105 http://dx.doi.org/10.1016/j.tranon.2020.100856 |